chemotherapy

chemotherapy

Dr. Swain on the Impact of Chemotherapy on Outcomes in HER2-Positive Metastatic Breast Cancer

6h ago
SOURCE  

Description

Sandra M. Swain, MD, Medical Director of the Washington Cancer Institute at MedStar Washington Hospital Center, discusses a taxane’s impact on outcomes in patients with HER2-positive metastatic breast cancer. More on breast cancer: http://www.onclive.com/specialty/breast-cancer